U.S. Physical Therapy (USPH) to Release Earnings on Wednesday

Posted by Stanley Muller on Jul 29th, 2026

U.S. Physical Therapy (NYSE:USPH – Get Free Report) is expected to be issuing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of $0.85 per share and revenue of $211.36 million for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 10:30 AM ET.

U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The company had revenue of $198.29 million for the quarter, compared to analyst estimates of $200.94 million. During the same period in the prior year, the firm posted $0.48 earnings per share. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Stock Up 3.6%

Shares of U.S. Physical Therapy stock opened at $79.41 on Wednesday. U.S. Physical Therapy has a 52-week low of $58.19 and a 52-week high of $93.50. The company has a 50 day moving average of $67.71 and a 200 day moving average of $74.53. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $1.21 billion, a P/E ratio of 158.82, a P/E/G ratio of 2.12 and a beta of 1.15.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Friday, May 22nd were given a $0.46 dividend. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.3%. U.S. Physical Therapy’s dividend payout ratio is currently 368.00%.

Insider Activity at U.S. Physical Therapy

In related news, Director Peter Francis Minan purchased 492 shares of the business’s stock in a transaction that occurred on Monday, June 8th. The shares were purchased at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the purchase, the director directly owned 2,923 shares of the company’s stock, valued at $184,558.22. The trade was a 20.24% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds have recently made changes to their positions in the company. Advisory Services Network LLC acquired a new stake in shares of U.S. Physical Therapy during the third quarter worth about $39,000. iSAM Funds UK Ltd acquired a new stake in shares of U.S. Physical Therapy in the 3rd quarter valued at about $52,000. Aquatic Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 445.4% in the 3rd quarter. Aquatic Capital Management LLC now owns 1,369 shares of the company’s stock valued at $116,000 after purchasing an additional 1,118 shares during the period. Vestcor Inc purchased a new position in U.S. Physical Therapy during the 3rd quarter worth approximately $117,000. Finally, State of Wyoming increased its position in U.S. Physical Therapy by 85.3% during the second quarter. State of Wyoming now owns 1,575 shares of the company’s stock worth $123,000 after buying an additional 725 shares during the period.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on USPH shares. Barrington Research decreased their price objective on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Friday, May 29th. Citizens Jmp reaffirmed a “market outperform” rating and set a $98.00 price target on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and an average price target of $97.50.

Get Our Latest Stock Analysis on USPH

About U.S. Physical Therapy

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.